
SeaStar Medical fell 59.2% from $4.80 to $1.96, behind the S&P 500's +10.5%. Its worst day was Oct 5 (−24.3%), and its low came Nov 6 at $1.88.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-1.30 beat the $-1.50 estimate on $183,000.00 revenue (est. $250,000.00).
−17.4% · S&P 500 0.0%
SeaStar Medical shares rose 24.8%, while the S&P 500 fell 0.2%.
Story events cover the past 12 months · Times ET
+24.8% · S&P 500 −0.2%
EPS of $-0.80 beat the $-1.00 estimate on $420,000.00 revenue (est. $423,500.00).
+22.4% · S&P 500 −1.8%
EPS of $-0.90 missed the $-0.81 estimate on $495,000.00 revenue (est. $450,000.00).
−8.7% · S&P 500 +0.8%
SeaStar Medical closed at its highest level of the year, 5.9% above where the year started.
+0.2% · S&P 500 −0.3%
EPS of $-0.91 beat the $-0.96 estimate on $615,000.00 revenue (est. $489,200.00).
−5.7% · S&P 500 +0.7%
SeaStar Medical shares rose 25.1%, while the S&P 500 rose 0.7%.
+25.1% · S&P 500 +0.7%
Where it ended: a close of $1.96 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 11, 2026 (EPS est. $-0.95, revenue est. $500,000.00).
Nothing in the past 12 months.
All ICU dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ICU and SPY from Benzinga historical bars. Not investment advice.